(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
My skin feels drier, my lips thinner and my makeup heavier. How do I adjust my routine for aging skin? - 2Palestinian infant freezes to death in Gaza as Israel keeps blocking aid
- 3These Are the Journalists Israel Has Killed Since the Start of the Iran War
- 4See a half-lit moon shine among the stars of Aquarius on Nov. 27
- 5Interstellar comet 3I/ATLAS' journey through our solar system, in photos
- The Force of Mentorship: Self-improvement through Direction
- Triumph’s Gorgeous, Super-Affordable and Approachable New Street Motos Share a Heart But Not a Soul
- Texas cities have some of the highest preterm birth rates in the US, highlighting maternal health crisis nationwide
- Blood pressure drug recalled for possible cross-contamination
- NASA’s Artemis II launch leaves Americans in awe: ‘We’re going to the frickin’ moon!’
- Supreme Court case about ‘crisis pregnancy centers’ highlights debate over truthful advertising standards
- Investigating Remarkable Espresso Flavors: Upgrade Your Day to day Blend
- Is Iran using cryptocurrencies to circumvent sanctions?
- Dependable Savvy Locks to Update Your Home Security
